Qualitative Findings on the Impact of Disease in Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Patients, as Measured by EQ-5D, SF-36, and the FACT-LYM

INTRODUCTION: There are no validated patient-reported outcome (PRO) instruments for Epstein–Barr virus-driven post-transplant lymphoproliferative disease (EBV(+) PTLD). The aim of this study was to assess the content applicability for three frequently used PRO instruments from the perspective of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Crystal, Barlev, Arie, Cole, Jason C., Trivedi, Bhumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683689/
https://www.ncbi.nlm.nih.gov/pubmed/33052502
http://dx.doi.org/10.1007/s40487-020-00131-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683689/
https://www.ncbi.nlm.nih.gov/pubmed/33052502
http://dx.doi.org/10.1007/s40487-020-00131-3

Ejemplares similares